Picture of Compugen logo

CGEN Compugen Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Annual cashflow statement for Compugen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2020
December 31st
C2021
December 31st
C2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:20-F20-F20-F20-F20-F
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-29.7-34.2-33.7-18.8-14.2
Depreciation
Non-Cash Items2.944.234.653.11.3
Unusual Items
Other Non-Cash Items
Changes in Working Capital-2.286.82-5.55-20.762
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Other Assets
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-28.3-22.7-34.1-35.949.6
Capital Expenditures-0.166-0.292-0.487-0.172-0.118
Purchase of Fixed Assets
Other Investing Cash Flow Items-826.9137.535.7-46.1
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-82.26.6237.135.5-46.3
Net Issuance / Retirement of Stock
Cash from Financing Activities10816.80.3533.080.554
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-2.030.7042.912.833.97